NIH-funded research R01 grant

Understanding a New Way to Control Heart Rhythm Problems

Official title: Novel Roles of Protein phosphatase 2A in Cardiac Arrhythmia

Funded at Ohio State University · NIH-11128719 · Data updated 2026-11-12

This work explores how a specific protein in the heart helps regulate electrical signals, aiming to find new ways to prevent dangerous heart rhythm issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startJuly 1, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$642,466
NIH project number5R01HL175380-02
Project IDNIH-11128719 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research is for patients interested in the underlying causes of cardiac arrhythmias, particularly those related to sodium channel dysfunction and sudden cardiac death.

Less likely to help

Patients seeking immediate treatment options or direct clinical trial participation may not find direct benefit from this early-stage basic science research.

What this research studies

Sudden cardiac death and irregular heartbeats, known as arrhythmias, are serious health concerns worldwide. This project focuses on tiny electrical channels in the heart called voltage-gated sodium channels, which are crucial for how heart muscle cells work. While we know a lot about how these channels cause problems, less is understood about how to turn down their harmful activity. We are looking at a protein called PP2A and its B56α part, which appears to play a key role in controlling these electrical signals and could offer a new target for treatments.

Why it matters

Potential benefit: If successful, this work could lead to new medications or therapies that specifically target the identified protein pathway to prevent or treat life-threatening cardiac arrhythmias.

How similar studies have gone: Previous work by this team has identified this pathway, suggesting a promising new direction for understanding and potentially treating arrhythmias.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: El Refaey, Mona — Ohio State University
  • Study coordinator: El Refaey, Mona

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.